...
首页> 外文期刊>Drugs of the Future >47 th Annual Meeting of the American Society of Clinical Oncology (ASCO) 2011: Focus on first-in-human and phase I trials
【24h】

47 th Annual Meeting of the American Society of Clinical Oncology (ASCO) 2011: Focus on first-in-human and phase I trials

机译:2011年美国临床肿瘤学会(ASCO)第47届年会:专注于首次人类试验和I期试验

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

"Patients. Pathways. Progress." was the collective theme of the 47 th Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago on June 3-7, 2011. Participants at the largest oncology meeting in the world were given the opportunity to exchange a wide range of ideas related to cancer and discussed the most recent advances in cancer research and care. This year's meeting was designed to accommodate the interests of the Society's multidisciplinary membership, whereas the educational program centered on medical, surgical and radiation oncology. This report will focus on the latest developments based on findings from a number of first-in-human trials and phase I studies presented at the meeting.
机译:“患者。途径。进步。”是2011年6月3日至7日在芝加哥举行的美国临床肿瘤学会(ASCO)第47届年会的共同主题。世界上最大的肿瘤学会议的参加者有机会进行广泛的交流与癌症有关的想法,并讨论了癌症研究和护理的最新进展。今年的会议旨在适应学会多学科成员的利益,而教育计划则以医学,外科和放射肿瘤学为中心。该报告将基于会议上提出的许多首次人体试验和第一阶段研究的结果,重点关注最新发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号